IE44230B1 - 1,3-diaza-bicyclo/3,2,0/ heptane derivatives - Google Patents

1,3-diaza-bicyclo/3,2,0/ heptane derivatives

Info

Publication number
IE44230B1
IE44230B1 IE1953/76A IE195376A IE44230B1 IE 44230 B1 IE44230 B1 IE 44230B1 IE 1953/76 A IE1953/76 A IE 1953/76A IE 195376 A IE195376 A IE 195376A IE 44230 B1 IE44230 B1 IE 44230B1
Authority
IE
Ireland
Prior art keywords
compound
oxo
carbon atoms
cis
formula
Prior art date
Application number
IE1953/76A
Other languages
English (en)
Other versions
IE44230L (en
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/610,517 external-priority patent/US4000154A/en
Application filed by Smithkline Corp filed Critical Smithkline Corp
Priority to IE1921/80A priority Critical patent/IE44231B1/en
Publication of IE44230L publication Critical patent/IE44230L/xx
Publication of IE44230B1 publication Critical patent/IE44230B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IE1953/76A 1975-09-03 1976-09-01 1,3-diaza-bicyclo/3,2,0/ heptane derivatives IE44230B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE1921/80A IE44231B1 (en) 1975-09-03 1976-09-01 3-amino-4-oxazetidine derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/610,517 US4000154A (en) 1975-09-03 1975-09-03 3-Substituted-6β-(amino- and acylamino)-7-oxo-1,3-diazabicyclo[3.2.0]-h
US68780576A 1976-05-19 1976-05-19

Publications (2)

Publication Number Publication Date
IE44230L IE44230L (en) 1977-03-03
IE44230B1 true IE44230B1 (en) 1981-09-23

Family

ID=27086273

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1953/76A IE44230B1 (en) 1975-09-03 1976-09-01 1,3-diaza-bicyclo/3,2,0/ heptane derivatives

Country Status (7)

Country Link
JP (1) JPS6055507B2 (nl)
CH (1) CH633290A5 (nl)
DE (1) DE2639397A1 (nl)
FR (2) FR2361885A1 (nl)
GB (2) GB1566261A (nl)
IE (1) IE44230B1 (nl)
NL (1) NL7609838A (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3108089C2 (de) * 1981-03-04 1987-01-15 Focke & Co, 2810 Verden Vorrichtung zum Auftragen von Leim auf Lappen von Verpackungen
GB2151628B (en) * 1981-10-23 1986-05-21 Roussel Uclaf Azetidine intermediates
FR2515182B1 (fr) * 1981-10-23 1986-05-09 Roussel Uclaf Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation
JPS6316908U (nl) * 1986-07-19 1988-02-04

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2219601A1 (de) * 1971-04-27 1972-11-16 Astra Läkemedel AB, Södertälje (Schweden) beta-Lactame und Verfahren zu deren Herstellung
SE417206B (sv) * 1973-03-13 1981-03-02 Merck & Co Inc Forfarande for framstellning av foreningar med autibiotisk verkan
DE2356862A1 (de) * 1973-11-14 1975-05-15 Univ Kingston Sauerstoffanaloga von 6-aminopenicillansaeurederivaten und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE2639397A1 (de) 1977-03-10
JPS5239695A (en) 1977-03-28
JPS6055507B2 (ja) 1985-12-05
FR2344534A1 (fr) 1977-10-14
CH633290A5 (en) 1982-11-30
FR2361885B1 (nl) 1980-03-14
FR2344534B1 (nl) 1980-07-04
NL7609838A (nl) 1977-03-07
GB1566262A (en) 1980-04-30
IE44230L (en) 1977-03-03
GB1566261A (en) 1980-04-30
FR2361885A1 (fr) 1978-03-17

Similar Documents

Publication Publication Date Title
US4260743A (en) Preparation of β-lactams and intermediates therefor
EP0005889B1 (en) Process for the preparation of beta-lactam derivatives, the novel derivatives so obtainable and pharmaceutical compositions containing them
US4684662A (en) Disubstituted proline derivatives
KR950013767B1 (ko) 키랄성 아제티디논 화합물 및 이의 제조방법
US4200572A (en) Substituted azetidinones
JPS6140236B2 (nl)
US4122262A (en) Intermediates and methods for preparing 7-acylamino-8-oxo-oxa-1-azabicyclo[4.2.0]octane-2-carboxylic acid derivatives
US4000154A (en) 3-Substituted-6β-(amino- and acylamino)-7-oxo-1,3-diazabicyclo[3.2.0]-h
US4122086A (en) Isopenicillins
US4708956A (en) 3-position halogenated cephalosporin analogs and pharmaceutical compositions
IE44230B1 (en) 1,3-diaza-bicyclo/3,2,0/ heptane derivatives
US4166816A (en) Methods and intermediates for preparing cis-4-oxoazetidine intermediates
EP0018546B1 (en) Process for the production of phenylglycyl chloride hydrochlorides
US4590073A (en) 6-substituted penicillanic acid 1,1-dioxide compounds
CA1120935A (en) MONOCYCLIC .beta.-LACTAMS WITH ANTIBACTERIAL ACTIVITY
US4103086A (en) 8-Oxo-4-thia-1-azabicyclo (4.2.0)-oct-2-ene derivatives
US4665166A (en) Process for preparing cephalosporin compounds
IE51358B1 (en) 1,2,4-triazinylthiomethyl-3-cephem sulfoxides,process for their preparation and pharmaceutical compositions containing them
JPS62252786A (ja) ４−置換β−ラクタム化合物
KR870000528B1 (ko) 3-아지도 세팔로스포린의 제조방법
EP0122157A2 (en) Improvements in or relating to indolylglycyl cephalosporin derivatives
US4556513A (en) Process for the production of antibiotic 1-oxadethiacephalosporins, and intermediate
EP0122158A2 (en) Improvements in or relating to benzothienyl cephalosporin antibiotics
US4613462A (en) 6-substituted penicillanic acid 1,1-dioxide compounds
EP0081824B1 (en) Processes for the production of antibiotic 1-oxadethiacephalosporins